Global RNA Interference Technology Market Growth 2022-2028
The global market for RNA Interference Technology is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC RNA Interference Technology market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States RNA Interference Technology market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe RNA Interference Technology market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China RNA Interference Technology market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key RNA Interference Technology players cover Alnylam Pharmaceuticals, Arcturus Therapeutics Holdings, Arrowhead Pharmaceuticals, AstraZeneca and Atalanta Therapeutics, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global RNA Interference Technology market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global RNA Interference Technology market, with both quantitative and qualitative data, to help readers understand how the RNA Interference Technology market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the RNA Interference Technology market and forecasts the market size by Type (dsRNA and miRNA,), by Application (Drug Discovery and Development, Diagnostic Centers and Others,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
dsRNA
miRNA
Segmentation by application
Drug Discovery and Development
Diagnostic Centers
Others
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Alnylam Pharmaceuticals
Arcturus Therapeutics Holdings
Arrowhead Pharmaceuticals
AstraZeneca
Atalanta Therapeutics
Bioneer Corporation
CureVac N.V.
Dicerna Pharmaceuticals
Gradalis
Ionis Pharmaceuticals
Merck KGaA
Nutcracker Therapeutics
Phio Pharmaceuticals
Sirnaomics
Chapter Introduction
Chapter 1: Scope of RNA Interference Technology, Research Methodology, etc.
Chapter 2: Executive Summary, global RNA Interference Technology market size (sales and revenue) and CAGR, RNA Interference Technology market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: RNA Interference Technology sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global RNA Interference Technology sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global RNA Interference Technology market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Alnylam Pharmaceuticals, Arcturus Therapeutics Holdings, Arrowhead Pharmaceuticals, AstraZeneca, Atalanta Therapeutics, Bioneer Corporation, CureVac N.V., Dicerna Pharmaceuticals and Gradalis, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global RNA Interference Technology Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for RNA Interference Technology by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for RNA Interference Technology by Country/Region, 2017, 2022 & 2028
2.2 RNA Interference Technology Segment by Type
2.2.1 dsRNA
2.2.2 miRNA
2.3 RNA Interference Technology Sales by Type
2.3.1 Global RNA Interference Technology Sales Market Share by Type (2017-2022)
2.3.2 Global RNA Interference Technology Revenue and Market Share by Type (2017-2022)
2.3.3 Global RNA Interference Technology Sale Price by Type (2017-2022)
2.4 RNA Interference Technology Segment by Application
2.4.1 Drug Discovery and Development
2.4.2 Diagnostic Centers
2.4.3 Others
2.5 RNA Interference Technology Sales by Application
2.5.1 Global RNA Interference Technology Sale Market Share by Application (2017-2022)
2.5.2 Global RNA Interference Technology Revenue and Market Share by Application (2017-2022)
2.5.3 Global RNA Interference Technology Sale Price by Application (2017-2022)
3 Global RNA Interference Technology by Company
3.1 Global RNA Interference Technology Breakdown Data by Company
3.1.1 Global RNA Interference Technology Annual Sales by Company (2020-2022)
3.1.2 Global RNA Interference Technology Sales Market Share by Company (2020-2022)
3.2 Global RNA Interference Technology Annual Revenue by Company (2020-2022)
3.2.1 Global RNA Interference Technology Revenue by Company (2020-2022)
3.2.2 Global RNA Interference Technology Revenue Market Share by Company (2020-2022)
3.3 Global RNA Interference Technology Sale Price by Company
3.4 Key Manufacturers RNA Interference Technology Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers RNA Interference Technology Product Location Distribution
3.4.2 Players RNA Interference Technology Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for RNA Interference Technology by Geographic Region
4.1 World Historic RNA Interference Technology Market Size by Geographic Region (2017-2022)
4.1.1 Global RNA Interference Technology Annual Sales by Geographic Region (2017-2022)
4.1.2 Global RNA Interference Technology Annual Revenue by Geographic Region
4.2 World Historic RNA Interference Technology Market Size by Country/Region (2017-2022)
4.2.1 Global RNA Interference Technology Annual Sales by Country/Region (2017-2022)
4.2.2 Global RNA Interference Technology Annual Revenue by Country/Region
4.3 Americas RNA Interference Technology Sales Growth
4.4 APAC RNA Interference Technology Sales Growth
4.5 Europe RNA Interference Technology Sales Growth
4.6 Middle East & Africa RNA Interference Technology Sales Growth
5 Americas
5.1 Americas RNA Interference Technology Sales by Country
5.1.1 Americas RNA Interference Technology Sales by Country (2017-2022)
5.1.2 Americas RNA Interference Technology Revenue by Country (2017-2022)
5.2 Americas RNA Interference Technology Sales by Type
5.3 Americas RNA Interference Technology Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC RNA Interference Technology Sales by Region
6.1.1 APAC RNA Interference Technology Sales by Region (2017-2022)
6.1.2 APAC RNA Interference Technology Revenue by Region (2017-2022)
6.2 APAC RNA Interference Technology Sales by Type
6.3 APAC RNA Interference Technology Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe RNA Interference Technology by Country
7.1.1 Europe RNA Interference Technology Sales by Country (2017-2022)
7.1.2 Europe RNA Interference Technology Revenue by Country (2017-2022)
7.2 Europe RNA Interference Technology Sales by Type
7.3 Europe RNA Interference Technology Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa RNA Interference Technology by Country
8.1.1 Middle East & Africa RNA Interference Technology Sales by Country (2017-2022)
8.1.2 Middle East & Africa RNA Interference Technology Revenue by Country (2017-2022)
8.2 Middle East & Africa RNA Interference Technology Sales by Type
8.3 Middle East & Africa RNA Interference Technology Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of RNA Interference Technology
10.3 Manufacturing Process Analysis of RNA Interference Technology
10.4 Industry Chain Structure of RNA Interference Technology
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 RNA Interference Technology Distributors
11.3 RNA Interference Technology Customer
12 World Forecast Review for RNA Interference Technology by Geographic Region
12.1 Global RNA Interference Technology Market Size Forecast by Region
12.1.1 Global RNA Interference Technology Forecast by Region (2023-2028)
12.1.2 Global RNA Interference Technology Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global RNA Interference Technology Forecast by Type
12.7 Global RNA Interference Technology Forecast by Application
13 Key Players Analysis
13.1 Alnylam Pharmaceuticals
13.1.1 Alnylam Pharmaceuticals Company Information
13.1.2 Alnylam Pharmaceuticals RNA Interference Technology Product Offered
13.1.3 Alnylam Pharmaceuticals RNA Interference Technology Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Alnylam Pharmaceuticals Main Business Overview
13.1.5 Alnylam Pharmaceuticals Latest Developments
13.2 Arcturus Therapeutics Holdings
13.2.1 Arcturus Therapeutics Holdings Company Information
13.2.2 Arcturus Therapeutics Holdings RNA Interference Technology Product Offered
13.2.3 Arcturus Therapeutics Holdings RNA Interference Technology Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Arcturus Therapeutics Holdings Main Business Overview
13.2.5 Arcturus Therapeutics Holdings Latest Developments
13.3 Arrowhead Pharmaceuticals
13.3.1 Arrowhead Pharmaceuticals Company Information
13.3.2 Arrowhead Pharmaceuticals RNA Interference Technology Product Offered
13.3.3 Arrowhead Pharmaceuticals RNA Interference Technology Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Arrowhead Pharmaceuticals Main Business Overview
13.3.5 Arrowhead Pharmaceuticals Latest Developments
13.4 AstraZeneca
13.4.1 AstraZeneca Company Information
13.4.2 AstraZeneca RNA Interference Technology Product Offered
13.4.3 AstraZeneca RNA Interference Technology Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 AstraZeneca Main Business Overview
13.4.5 AstraZeneca Latest Developments
13.5 Atalanta Therapeutics
13.5.1 Atalanta Therapeutics Company Information
13.5.2 Atalanta Therapeutics RNA Interference Technology Product Offered
13.5.3 Atalanta Therapeutics RNA Interference Technology Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Atalanta Therapeutics Main Business Overview
13.5.5 Atalanta Therapeutics Latest Developments
13.6 Bioneer Corporation
13.6.1 Bioneer Corporation Company Information
13.6.2 Bioneer Corporation RNA Interference Technology Product Offered
13.6.3 Bioneer Corporation RNA Interference Technology Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Bioneer Corporation Main Business Overview
13.6.5 Bioneer Corporation Latest Developments
13.7 CureVac N.V.
13.7.1 CureVac N.V. Company Information
13.7.2 CureVac N.V. RNA Interference Technology Product Offered
13.7.3 CureVac N.V. RNA Interference Technology Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 CureVac N.V. Main Business Overview
13.7.5 CureVac N.V. Latest Developments
13.8 Dicerna Pharmaceuticals
13.8.1 Dicerna Pharmaceuticals Company Information
13.8.2 Dicerna Pharmaceuticals RNA Interference Technology Product Offered
13.8.3 Dicerna Pharmaceuticals RNA Interference Technology Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Dicerna Pharmaceuticals Main Business Overview
13.8.5 Dicerna Pharmaceuticals Latest Developments
13.9 Gradalis
13.9.1 Gradalis Company Information
13.9.2 Gradalis RNA Interference Technology Product Offered
13.9.3 Gradalis RNA Interference Technology Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Gradalis Main Business Overview
13.9.5 Gradalis Latest Developments
13.10 Ionis Pharmaceuticals
13.10.1 Ionis Pharmaceuticals Company Information
13.10.2 Ionis Pharmaceuticals RNA Interference Technology Product Offered
13.10.3 Ionis Pharmaceuticals RNA Interference Technology Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Ionis Pharmaceuticals Main Business Overview
13.10.5 Ionis Pharmaceuticals Latest Developments
13.11 Merck KGaA
13.11.1 Merck KGaA Company Information
13.11.2 Merck KGaA RNA Interference Technology Product Offered
13.11.3 Merck KGaA RNA Interference Technology Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Merck KGaA Main Business Overview
13.11.5 Merck KGaA Latest Developments
13.12 Nutcracker Therapeutics
13.12.1 Nutcracker Therapeutics Company Information
13.12.2 Nutcracker Therapeutics RNA Interference Technology Product Offered
13.12.3 Nutcracker Therapeutics RNA Interference Technology Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Nutcracker Therapeutics Main Business Overview
13.12.5 Nutcracker Therapeutics Latest Developments
13.13 Phio Pharmaceuticals
13.13.1 Phio Pharmaceuticals Company Information
13.13.2 Phio Pharmaceuticals RNA Interference Technology Product Offered
13.13.3 Phio Pharmaceuticals RNA Interference Technology Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Phio Pharmaceuticals Main Business Overview
13.13.5 Phio Pharmaceuticals Latest Developments
13.14 Sirnaomics
13.14.1 Sirnaomics Company Information
13.14.2 Sirnaomics RNA Interference Technology Product Offered
13.14.3 Sirnaomics RNA Interference Technology Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Sirnaomics Main Business Overview
13.14.5 Sirnaomics Latest Developments
14 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. RNA Interference Technology Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. RNA Interference Technology Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of dsRNA
Table 4. Major Players of miRNA
Table 5. Global RNA Interference Technology Sales by Type (2017-2022) & (K Units)
Table 6. Global RNA Interference Technology Sales Market Share by Type (2017-2022)
Table 7. Global RNA Interference Technology Revenue by Type (2017-2022) & ($ million)
Table 8. Global RNA Interference Technology Revenue Market Share by Type (2017-2022)
Table 9. Global RNA Interference Technology Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global RNA Interference Technology Sales by Application (2017-2022) & (K Units)
Table 11. Global RNA Interference Technology Sales Market Share by Application (2017-2022)
Table 12. Global RNA Interference Technology Revenue by Application (2017-2022)
Table 13. Global RNA Interference Technology Revenue Market Share by Application (2017-2022)
Table 14. Global RNA Interference Technology Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global RNA Interference Technology Sales by Company (2020-2022) & (K Units)
Table 16. Global RNA Interference Technology Sales Market Share by Company (2020-2022)
Table 17. Global RNA Interference Technology Revenue by Company (2020-2022) ($ Millions)
Table 18. Global RNA Interference Technology Revenue Market Share by Company (2020-2022)
Table 19. Global RNA Interference Technology Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers RNA Interference Technology Producing Area Distribution and Sales Area
Table 21. Players RNA Interference Technology Products Offered
Table 22. RNA Interference Technology Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global RNA Interference Technology Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global RNA Interference Technology Sales Market Share Geographic Region (2017-2022)
Table 27. Global RNA Interference Technology Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global RNA Interference Technology Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global RNA Interference Technology Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global RNA Interference Technology Sales Market Share by Country/Region (2017-2022)
Table 31. Global RNA Interference Technology Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global RNA Interference Technology Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas RNA Interference Technology Sales by Country (2017-2022) & (K Units)
Table 34. Americas RNA Interference Technology Sales Market Share by Country (2017-2022)
Table 35. Americas RNA Interference Technology Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas RNA Interference Technology Revenue Market Share by Country (2017-2022)
Table 37. Americas RNA Interference Technology Sales by Type (2017-2022) & (K Units)
Table 38. Americas RNA Interference Technology Sales Market Share by Type (2017-2022)
Table 39. Americas RNA Interference Technology Sales by Application (2017-2022) & (K Units)
Table 40. Americas RNA Interference Technology Sales Market Share by Application (2017-2022)
Table 41. APAC RNA Interference Technology Sales by Region (2017-2022) & (K Units)
Table 42. APAC RNA Interference Technology Sales Market Share by Region (2017-2022)
Table 43. APAC RNA Interference Technology Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC RNA Interference Technology Revenue Market Share by Region (2017-2022)
Table 45. APAC RNA Interference Technology Sales by Type (2017-2022) & (K Units)
Table 46. APAC RNA Interference Technology Sales Market Share by Type (2017-2022)
Table 47. APAC RNA Interference Technology Sales by Application (2017-2022) & (K Units)
Table 48. APAC RNA Interference Technology Sales Market Share by Application (2017-2022)
Table 49. Europe RNA Interference Technology Sales by Country (2017-2022) & (K Units)
Table 50. Europe RNA Interference Technology Sales Market Share by Country (2017-2022)
Table 51. Europe RNA Interference Technology Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe RNA Interference Technology Revenue Market Share by Country (2017-2022)
Table 53. Europe RNA Interference Technology Sales by Type (2017-2022) & (K Units)
Table 54. Europe RNA Interference Technology Sales Market Share by Type (2017-2022)
Table 55. Europe RNA Interference Technology Sales by Application (2017-2022) & (K Units)
Table 56. Europe RNA Interference Technology Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa RNA Interference Technology Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa RNA Interference Technology Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa RNA Interference Technology Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa RNA Interference Technology Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa RNA Interference Technology Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa RNA Interference Technology Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa RNA Interference Technology Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa RNA Interference Technology Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of RNA Interference Technology
Table 66. Key Market Challenges & Risks of RNA Interference Technology
Table 67. Key Industry Trends of RNA Interference Technology
Table 68. RNA Interference Technology Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. RNA Interference Technology Distributors List
Table 71. RNA Interference Technology Customer List
Table 72. Global RNA Interference Technology Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global RNA Interference Technology Sales Market Forecast by Region
Table 74. Global RNA Interference Technology Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global RNA Interference Technology Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas RNA Interference Technology Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas RNA Interference Technology Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC RNA Interference Technology Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC RNA Interference Technology Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe RNA Interference Technology Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe RNA Interference Technology Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa RNA Interference Technology Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa RNA Interference Technology Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global RNA Interference Technology Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global RNA Interference Technology Sales Market Share Forecast by Type (2023-2028)
Table 86. Global RNA Interference Technology Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global RNA Interference Technology Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global RNA Interference Technology Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global RNA Interference Technology Sales Market Share Forecast by Application (2023-2028)
Table 90. Global RNA Interference Technology Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global RNA Interference Technology Revenue Market Share Forecast by Application (2023-2028)
Table 92. Alnylam Pharmaceuticals Basic Information, RNA Interference Technology Manufacturing Base, Sales Area and Its Competitors
Table 93. Alnylam Pharmaceuticals RNA Interference Technology Product Offered
Table 94. Alnylam Pharmaceuticals RNA Interference Technology Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. Alnylam Pharmaceuticals Main Business
Table 96. Alnylam Pharmaceuticals Latest Developments
Table 97. Arcturus Therapeutics Holdings Basic Information, RNA Interference Technology Manufacturing Base, Sales Area and Its Competitors
Table 98. Arcturus Therapeutics Holdings RNA Interference Technology Product Offered
Table 99. Arcturus Therapeutics Holdings RNA Interference Technology Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. Arcturus Therapeutics Holdings Main Business
Table 101. Arcturus Therapeutics Holdings Latest Developments
Table 102. Arrowhead Pharmaceuticals Basic Information, RNA Interference Technology Manufacturing Base, Sales Area and Its Competitors
Table 103. Arrowhead Pharmaceuticals RNA Interference Technology Product Offered
Table 104. Arrowhead Pharmaceuticals RNA Interference Technology Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Arrowhead Pharmaceuticals Main Business
Table 106. Arrowhead Pharmaceuticals Latest Developments
Table 107. AstraZeneca Basic Information, RNA Interference Technology Manufacturing Base, Sales Area and Its Competitors
Table 108. AstraZeneca RNA Interference Technology Product Offered
Table 109. AstraZeneca RNA Interference Technology Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. AstraZeneca Main Business
Table 111. AstraZeneca Latest Developments
Table 112. Atalanta Therapeutics Basic Information, RNA Interference Technology Manufacturing Base, Sales Area and Its Competitors
Table 113. Atalanta Therapeutics RNA Interference Technology Product Offered
Table 114. Atalanta Therapeutics RNA Interference Technology Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. Atalanta Therapeutics Main Business
Table 116. Atalanta Therapeutics Latest Developments
Table 117. Bioneer Corporation Basic Information, RNA Interference Technology Manufacturing Base, Sales Area and Its Competitors
Table 118. Bioneer Corporation RNA Interference Technology Product Offered
Table 119. Bioneer Corporation RNA Interference Technology Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. Bioneer Corporation Main Business
Table 121. Bioneer Corporation Latest Developments
Table 122. CureVac N.V. Basic Information, RNA Interference Technology Manufacturing Base, Sales Area and Its Competitors
Table 123. CureVac N.V. RNA Interference Technology Product Offered
Table 124. CureVac N.V. RNA Interference Technology Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. CureVac N.V. Main Business
Table 126. CureVac N.V. Latest Developments
Table 127. Dicerna Pharmaceuticals Basic Information, RNA Interference Technology Manufacturing Base, Sales Area and Its Competitors
Table 128. Dicerna Pharmaceuticals RNA Interference Technology Product Offered
Table 129. Dicerna Pharmaceuticals RNA Interference Technology Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 130. Dicerna Pharmaceuticals Main Business
Table 131. Dicerna Pharmaceuticals Latest Developments
Table 132. Gradalis Basic Information, RNA Interference Technology Manufacturing Base, Sales Area and Its Competitors
Table 133. Gradalis RNA Interference Technology Product Offered
Table 134. Gradalis RNA Interference Technology Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 135. Gradalis Main Business
Table 136. Gradalis Latest Developments
Table 137. Ionis Pharmaceuticals Basic Information, RNA Interference Technology Manufacturing Base, Sales Area and Its Competitors
Table 138. Ionis Pharmaceuticals RNA Interference Technology Product Offered
Table 139. Ionis Pharmaceuticals RNA Interference Technology Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 140. Ionis Pharmaceuticals Main Business
Table 141. Ionis Pharmaceuticals Latest Developments
Table 142. Merck KGaA Basic Information, RNA Interference Technology Manufacturing Base, Sales Area and Its Competitors
Table 143. Merck KGaA RNA Interference Technology Product Offered
Table 144. Merck KGaA RNA Interference Technology Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 145. Merck KGaA Main Business
Table 146. Merck KGaA Latest Developments
Table 147. Nutcracker Therapeutics Basic Information, RNA Interference Technology Manufacturing Base, Sales Area and Its Competitors
Table 148. Nutcracker Therapeutics RNA Interference Technology Product Offered
Table 149. Nutcracker Therapeutics RNA Interference Technology Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 150. Nutcracker Therapeutics Main Business
Table 151. Nutcracker Therapeutics Latest Developments
Table 152. Phio Pharmaceuticals Basic Information, RNA Interference Technology Manufacturing Base, Sales Area and Its Competitors
Table 153. Phio Pharmaceuticals RNA Interference Technology Product Offered
Table 154. Phio Pharmaceuticals RNA Interference Technology Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 155. Phio Pharmaceuticals Main Business
Table 156. Phio Pharmaceuticals Latest Developments
Table 157. Sirnaomics Basic Information, RNA Interference Technology Manufacturing Base, Sales Area and Its Competitors
Table 158. Sirnaomics RNA Interference Technology Product Offered
Table 159. Sirnaomics RNA Interference Technology Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 160. Sirnaomics Main Business
Table 161. Sirnaomics Latest Developments
List of Figures
Figure 1. Picture of RNA Interference Technology
Figure 2. RNA Interference Technology Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global RNA Interference Technology Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global RNA Interference Technology Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. RNA Interference Technology Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of dsRNA
Figure 10. Product Picture of miRNA
Figure 11. Global RNA Interference Technology Sales Market Share by Type in 2021
Figure 12. Global RNA Interference Technology Revenue Market Share by Type (2017-2022)
Figure 13. RNA Interference Technology Consumed in Drug Discovery and Development
Figure 14. Global RNA Interference Technology Market: Drug Discovery and Development (2017-2022) & (K Units)
Figure 15. RNA Interference Technology Consumed in Diagnostic Centers
Figure 16. Global RNA Interference Technology Market: Diagnostic Centers (2017-2022) & (K Units)
Figure 17. RNA Interference Technology Consumed in Others
Figure 18. Global RNA Interference Technology Market: Others (2017-2022) & (K Units)
Figure 19. Global RNA Interference Technology Sales Market Share by Application (2017-2022)
Figure 20. Global RNA Interference Technology Revenue Market Share by Application in 2021
Figure 21. RNA Interference Technology Revenue Market by Company in 2021 ($ Million)
Figure 22. Global RNA Interference Technology Revenue Market Share by Company in 2021
Figure 23. Global RNA Interference Technology Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global RNA Interference Technology Revenue Market Share by Geographic Region in 2021
Figure 25. Global RNA Interference Technology Sales Market Share by Region (2017-2022)
Figure 26. Global RNA Interference Technology Revenue Market Share by Country/Region in 2021
Figure 27. Americas RNA Interference Technology Sales 2017-2022 (K Units)
Figure 28. Americas RNA Interference Technology Revenue 2017-2022 ($ Millions)
Figure 29. APAC RNA Interference Technology Sales 2017-2022 (K Units)
Figure 30. APAC RNA Interference Technology Revenue 2017-2022 ($ Millions)
Figure 31. Europe RNA Interference Technology Sales 2017-2022 (K Units)
Figure 32. Europe RNA Interference Technology Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa RNA Interference Technology Sales 2017-2022 (K Units)
Figure 34. Middle East & Africa RNA Interference Technology Revenue 2017-2022 ($ Millions)
Figure 35. Americas RNA Interference Technology Sales Market Share by Country in 2021
Figure 36. Americas RNA Interference Technology Revenue Market Share by Country in 2021
Figure 37. United States RNA Interference Technology Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada RNA Interference Technology Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico RNA Interference Technology Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil RNA Interference Technology Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC RNA Interference Technology Sales Market Share by Region in 2021
Figure 42. APAC RNA Interference Technology Revenue Market Share by Regions in 2021
Figure 43. China RNA Interference Technology Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan RNA Interference Technology Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea RNA Interference Technology Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia RNA Interference Technology Revenue Growth 2017-2022 ($ Millions)
Figure 47. India RNA Interference Technology Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia RNA Interference Technology Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe RNA Interference Technology Sales Market Share by Country in 2021
Figure 50. Europe RNA Interference Technology Revenue Market Share by Country in 2021
Figure 51. Germany RNA Interference Technology Revenue Growth 2017-2022 ($ Millions)
Figure 52. France RNA Interference Technology Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK RNA Interference Technology Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy RNA Interference Technology Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia RNA Interference Technology Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa RNA Interference Technology Sales Market Share by Country in 2021
Figure 57. Middle East & Africa RNA Interference Technology Revenue Market Share by Country in 2021
Figure 58. Egypt RNA Interference Technology Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa RNA Interference Technology Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel RNA Interference Technology Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey RNA Interference Technology Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country RNA Interference Technology Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of RNA Interference Technology in 2021
Figure 64. Manufacturing Process Analysis of RNA Interference Technology
Figure 65. Industry Chain Structure of RNA Interference Technology
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
Reason to Buy
- Current and future of Medical Devices & Consumables Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Medical Devices & Consumables Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Medical Devices & Consumables Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Medical Devices & Consumables Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets